NewsLife Sciences
Comet assay: mutagenicity testing for chemical risk assessment
23 Sept 2007Tessa Lomax
Marketing / Sales
Product news
The World Health Organisation has issued a draft document for public and peer review on a revised strategy for mutagenicity testing. This has been produced as a result of the harmonisation project conducted within the International Programme on Chemical Safety (IPCS).
This suggests the use of the Comet Assay where appropriate as one of the in vivo tests used in the mutagenicity testing strategy. The main attributes cited for the comet assay are that it can be applied to many tissues, improved specificity with enzymes and that cell division is not required.
As yet there is no OECD Guideline in place for the assay, but guidance has been published by the IWGT, the most recent being Burlinson et al (2007).
Links
Tags
ADME-ToxicologyADME-toxicology (ADME-Tox) studies are used in pharmacology and pharmacokinetics to assess the activity/toxicity of drugs <i>in vivo</i> or <i>in vitro</i>. Find bioassays for absorption, distribution, metabolism, and excretion of drug molecules including cytotoxicity, transporter/permeability, metabolism and activity assays as well as hepatocytes and cell lines for ADME. Find the best ADME-toxicology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.
